Some of the stocks that may grab investor focus today are:
Wall Street expects FedEx Corporation (NYSE: FDX) to post quarterly earnings at $5.68 per share on revenue of $17.23 billion after the closing bell. FedEx shares fell 0.03 percent to $263.60 in after-hours trading. Tellurian Inc (NASDAQ: TELL) reported a 12 million share common stock offering. Tellurian shares dropped 4.41 percent to $10.40 in the after-hours trading session. Analysts are expecting Oracle Corporation (NYSE: ORCL) to have earned $0.94 per share on revenue of $11.19 billion in the latest quarter. Oracle will release earnings after the markets close. Oracle shares dropped 0.15 percent to $46.45 in after-hours trading. Viveve Medical Inc (NASDAQ: VIVE) shares climbed over 28 percent in after-hours trading after reporting six-month data from stress urinary incontinence feasibility study. Eighty-three percent of women treated experienced an improvement in one-hour pad weight and achieved clinically meaningful benefit across all quality of life outcome measures. Viveve Medical shares climbed 28.61 percent to $4.90 in the after-hours trading session.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Top 10 Medical Stocks To Watch For 2019: Gilat Satellite Networks Ltd.(GILT)
Advisors’ Opinion:
- [By Stephan Byrd]
BidaskClub cut shares of Gilat Satellite Networks (NASDAQ:GILT) from a hold rating to a sell rating in a report published on Saturday.
Separately, TheStreet raised Gilat Satellite Networks from a c+ rating to a b- rating in a research report on Thursday, August 30th.
- [By Logan Wallace]
Gilat Satellite Networks (NASDAQ: GILT) and Ceragon Networks (NASDAQ:CRNT) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, valuation, profitability and institutional ownership.
Top 10 Medical Stocks To Watch For 2019: Vanguard Mega Cap Value ETF (MGV)
Advisors’ Opinion:
- [By Shane Hupp]
Baird Financial Group Inc. purchased a new stake in Vanguard Mega Cap Value ETF (NYSEARCA:MGV) during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 10,229 shares of the company’s stock, valued at approximately $761,000.
Top 10 Medical Stocks To Watch For 2019: Bruker Corporation(BRKR)
Advisors’ Opinion:
- [By Stephan Byrd]
Bruker Co. (NASDAQ:BRKR) has received an average recommendation of “Hold” from the eleven brokerages that are currently covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and one has given a buy rating to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $34.38.
- [By Ethan Ryder]
Get a free copy of the Zacks research report on Bruker (BRKR)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Shane Hupp]
Get a free copy of the Zacks research report on Bruker (BRKR)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Logan Wallace]
Shares of Bruker Co. (NASDAQ:BRKR) have received a consensus rating of “Hold” from the twelve brokerages that are presently covering the company, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, seven have given a hold recommendation and three have issued a buy recommendation on the company. The average 12-month price target among brokerages that have covered the stock in the last year is $33.11.
- [By Stephan Byrd]
Here are some of the media stories that may have effected Accern’s rankings:
Get Bruker alerts:
Bruker Announces Improved Solutions for Microbial Strain Typing, Hospital Hygiene and Infection Control, and Candida auris Testing at ASM 2018 (finance.yahoo.com) Financial Review: Bruker (BRKR) versus Pacific Biosciences of California (PACB) (americanbankingnews.com) Global Microbiology Testing/Clinical Microbiology Market 2018-2024: Market is Influenced by Biomerieux, Abbott, Roche, Bruker and Bio-rad Labs (bizjournals.com) Bruker Corporation appoints Gerald Herman as CFO (seekingalpha.com) Bruker Corporation Appoints Gerald Herman as Chief Financial Officer (finance.yahoo.com)
A number of brokerages have issued reports on BRKR. Zacks Investment Research cut Bruker from a “buy” rating to a “hold” rating in a research report on Friday. BTIG Research set a $42.00 target price on Bruker and gave the stock a “buy” rating in a research report on Sunday, May 6th. BidaskClub raised Bruker from a “hold” rating to a “buy” rating in a research report on Wednesday, May 23rd. Bank of America decreased their target price on Bruker from $37.00 to $34.00 and set a “neutral” rating for the company in a research report on Friday, May 4th. Finally, Leerink Swann upped their target price on Bruker from $32.00 to $34.00 and gave the stock a “market perform” rating in a research report on Friday, February 9th. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $32.91.
- [By Shane Hupp]
Get a free copy of the Zacks research report on Bruker (BRKR)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top 10 Medical Stocks To Watch For 2019: GWG Holdings, Inc(GWGH)
Advisors’ Opinion:
- [By Shane Hupp]
Get a free copy of the Zacks research report on GWG (GWGH)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
Get a free copy of the Zacks research report on GWG (GWGH)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Logan Wallace]
ValuEngine cut shares of GWG (NASDAQ:GWGH) from a sell rating to a strong sell rating in a report issued on Friday morning.
Several other equities analysts have also issued reports on GWGH. Zacks Investment Research lowered GWG from a strong-buy rating to a hold rating in a research note on Tuesday, July 17th. Maxim Group reissued a buy rating and issued a $14.00 price target on shares of GWG in a research note on Thursday, August 16th.
- [By Shane Hupp]
Here are some of the news articles that may have effected Accern Sentiment’s analysis:
Get GWG alerts:
Critical Review: Citizens (CIA) vs. GWG (GWGH) (americanbankingnews.com) (Watch) Zibanejad scores in Sweden’s win over Russia (sny.tv) GWG Holdings’ (GWGH) CEO Jon Sabes on Q1 2018 Results – Earnings Call Transcript (msn.com) Edited Transcript of GWGH earnings conference call or presentation 14-May-18 8:30pm GMT (finance.yahoo.com) DWWA judge profile: Davide Buongiorno (decanter.com)
A number of equities research analysts recently commented on the company. Zacks Investment Research raised GWG from a “hold” rating to a “buy” rating and set a $9.25 price target for the company in a research report on Wednesday, April 11th. ValuEngine lowered GWG from a “hold” rating to a “sell” rating in a research report on Monday, May 14th. Finally, Maxim Group reaffirmed a “buy” rating and set a $14.00 target price on shares of GWG in a research report on Tuesday, January 23rd.
- [By Shane Hupp]
Get a free copy of the Zacks research report on GWG (GWGH)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top 10 Medical Stocks To Watch For 2019: Chuy's Holdings, Inc.(CHUY)
Advisors’ Opinion:
- [By Ethan Ryder]
Papa Murphy’s (NASDAQ: FRSH) and Chuy’s (NASDAQ:CHUY) are both small-cap retail/wholesale companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, profitability, analyst recommendations and valuation.
- [By Dan Caplinger]
Industries run into hot and cold spells, but the best companies find ways to navigate through the tough times and come out stronger than ever. For Tex-Mex restaurant chain Chuy’s Holdings (NASDAQ:CHUY), its expansion beyond its home market in the capital of the Lone Star State into new locations across the nation has been exciting. It’s also come with plenty of challenges, though, and shareholders in Chuy’s have had to endure rising competition and operational headwinds as the company tries to establish itself as a national player within a crowded space.
- [By Logan Wallace]
News headlines about Chuy’s (NASDAQ:CHUY) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies positive and negative press coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Chuy’s earned a media sentiment score of 0.15 on Accern’s scale. Accern also gave headlines about the restaurant operator an impact score of 46.3414123476192 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
- [By Shane Hupp]
Media headlines about Chuy’s (NASDAQ:CHUY) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies positive and negative news coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Chuy’s earned a coverage optimism score of 0.17 on Accern’s scale. Accern also assigned news articles about the restaurant operator an impact score of 45.384946677215 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
- [By Logan Wallace]
Chuy’s (NASDAQ:CHUY) was downgraded by equities researchers at ValuEngine from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Friday.
- [By Motley Fool Staff]
Chuy’s Holdings (NASDAQ:CHUY) Q1 2018 Earnings Conference CallMay. 8, 2018 4:30 p.m. ET
Contents:
Prepared Remarks Questions and Answers Call Participants
Prepared Remarks:Operator
Top 10 Medical Stocks To Watch For 2019: The ExOne Company(XONE)
Advisors’ Opinion:
- [By Stephan Byrd]
ExOne Co (NASDAQ:XONE) Director Lloyd A. Semple sold 1,250 shares of the business’s stock in a transaction on Wednesday, September 12th. The shares were sold at an average price of $8.48, for a total transaction of $10,600.00. Following the completion of the sale, the director now owns 28,500 shares in the company, valued at approximately $241,680. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.
- [By Max Byerly]
Shares of ExOne Co (NASDAQ:XONE) shot up 5.5% during mid-day trading on Thursday . The stock traded as high as $10.94 and last traded at $10.01. 5,080 shares traded hands during mid-day trading, a decline of 97% from the average session volume of 152,117 shares. The stock had previously closed at $10.59.
- [By Logan Wallace]
Shares of ExOne Co (NASDAQ:XONE) have earned a consensus recommendation of “Buy” from the six brokerages that are covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating, one has given a hold rating and four have assigned a buy rating to the company. The average 1 year target price among analysts that have covered the stock in the last year is $13.67.
- [By Motley Fool Transcribers]
The ExOne Company (NASDAQ:XONE)Q2 2018 Earnings Conference CallAug. 10, 2018, 8:30 a.m. ET
Contents:
Prepared Remarks Questions and Answers Call Participants
Prepared Remarks:Operator
- [By Paul Ausick]
Short interest in ExOne Co. (NASDAQ: XONE) fell by 3.9% to 2.75 million shares. About 28.2% of the company’s shares were short. ExOne’s share price rose by about 4.7% in the short interest period. The stock’s 52-week range is $6.16 to $12.50, and shares closed at $7.22 on Wednesday, down about 3.6% for the day. Days to cover fell from 17 to seven.
Top 10 Medical Stocks To Watch For 2019: Raytheon Company(RTN)
Advisors’ Opinion:
- [By Benzinga News Desk]
Coffee waste is now fetching a 480 percent premium over coffee itself. Prices for dried husks are outstripping those for beans: Link
ECONOMIC DATA
The Richmond Fed manufacturing index for May will be released at 10:00 a.m. ET.
The Treasury is set to auction 4-and 52-week bills at 11:30 a.m. ET.
The Treasury is set to auction 2-year notes at 1:00 p.m. ET.
ANALYST RATINGS
Susquehanna upgrades Macy's (NYSE: M) to Positive, Raises Price Target to $43
Deutsche Bank downgrades Manchester United (NYSE: MANU) to Hold, Lowers Price Target to $21
Credit Suisse downgrades Raytheon (NYSE: RTN) to Neutral, Announces $219 Price TargetThis is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.
- [By Lou Whiteman]
Raytheon (NYSE:RTN) and Honeywell (NYSE:HON) are two industrial powerhouses with exposure to red-hot end markets — defense in the case of Raytheon, and commercial aerospace and construction for Honeywell. But each has had its share of detractors in recent quarters.
- [By Rich Smith]
If you want an answer to that question, check out this latest video from Raytheon Company (NYSE:RTN) showing the company’s newest high-energy laser (HEL) shooting down small unmanned aerial vehicles in a series of tests.
- [By Logan Wallace]
Cannell Peter B & Co. Inc. reduced its position in shares of Raytheon (NYSE:RTN) by 1.3% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 39,286 shares of the aerospace company’s stock after selling 531 shares during the quarter. Cannell Peter B & Co. Inc.’s holdings in Raytheon were worth $7,589,000 as of its most recent filing with the Securities and Exchange Commission.
Top 10 Medical Stocks To Watch For 2019: NBT Bancorp Inc.(NBTB)
Advisors’ Opinion:
- [By Max Byerly]
Get a free copy of the Zacks research report on NBT Bancorp (NBTB)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
Get a free copy of the Zacks research report on NBT Bancorp (NBTB)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Ethan Ryder]
NBT Bancorp (NASDAQ:NBTB) was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating in a note issued to investors on Saturday.
Top 10 Medical Stocks To Watch For 2019: Del Taco Restaurants, Inc.(TACO)
Advisors’ Opinion:
- [By Stephan Byrd]
BidaskClub upgraded shares of Del Taco Restaurants (NASDAQ:TACO) from a sell rating to a hold rating in a report issued on Thursday morning.
Several other analysts also recently weighed in on the stock. ValuEngine raised shares of Del Taco Restaurants from a sell rating to a hold rating in a research note on Tuesday, June 5th. Zacks Investment Research raised shares of Del Taco Restaurants from a sell rating to a hold rating in a research note on Saturday, July 7th. Citigroup lifted their price target on shares of Del Taco Restaurants from $13.00 to $16.00 and gave the company a buy rating in a research note on Thursday, June 21st. TheStreet raised shares of Del Taco Restaurants from a c+ rating to a b- rating in a research note on Wednesday, July 18th. Finally, Dougherty & Co lifted their price target on shares of Del Taco Restaurants from $16.50 to $18.50 and gave the company a buy rating in a research note on Friday, July 6th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the stock. The stock has an average rating of Buy and an average target price of $16.06.
- [By Logan Wallace]
Lord Abbett & CO. LLC trimmed its stake in Del Taco Restaurants Inc (NASDAQ:TACO) by 69.9% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 111,068 shares of the restaurant operator’s stock after selling 257,475 shares during the period. Lord Abbett & CO. LLC owned about 0.29% of Del Taco Restaurants worth $1,150,000 as of its most recent filing with the SEC.
- [By Max Byerly]
Del Taco Restaurants Inc (NASDAQ:TACO) Director Patrick Walsh acquired 10,000 shares of the business’s stock in a transaction on Friday, May 18th. The stock was acquired at an average price of $11.43 per share, with a total value of $114,300.00. Following the transaction, the director now owns 31,866 shares in the company, valued at approximately $364,228.38. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
- [By Max Byerly]
The analysts wrote, “We maintain our Buy rating and $19 price target on Del Taco (TACO) as the company’s 3Q18 (September) draws to a close. We lower our 3Q18 (September) EPS estimate to $0.15, from $0.16, though maintain our above-guidance $0.63 EPS estimate for 2018. Our EPS estimates of $0.72 for 2019 (vs. $0.67 consensus) and $0.79 for 2020 are unchanged. We believe recent M&A activity in the industry will push TACO’s valuation multiples higher.””
- [By Stephan Byrd]
Arcos Dorados (NYSE:ARCO) and Del Taco Restaurants (NASDAQ:TACO) are both small-cap retail/wholesale companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, profitability, earnings, institutional ownership and risk.
Top 10 Medical Stocks To Watch For 2019: Physicians Realty Trust(DOC)
Advisors’ Opinion:
- [By Beth McKenna]
Shares of Physicians Realty Trust (NYSE:DOC) jumped 11% in August, according to data from S&P Global Market Intelligence .
This pop has helped propel the healthcare real estate investment trust (REIT) stock’s return to almost break-even for 2018. It’s returned negative 1.4% so far this year through Monday, Sept. 10.
- [By Matthew Frankel, CFP]
One interesting healthcare REIT is Physicians Realty Trust (NYSE:DOC), a relatively small but fast-growing REIT that focuses on medical office properties leased to major health systems. Here’s a rundown of why medical offices can be smart investments, as well as Physicians Realty Trust’s value as an investment right now.
- [By Tyler Crowe, Matthew Frankel, CFP, and Neha Chamaria]
So we asked three Motley Fool contributors to tell us about one of their favorite mid-cap stocks out there today. Here’s why they picked real estate investment trust (REIT) Physicians Realty Trust (NYSE:DOC), precious metal streaming company Royal Gold (NASDAQ:RGLD), and solar power component supplier SolarEdge Technologies (NASDAQ:SEDG).